UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 71

Sortiert nach

Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial

Europace (London, England), 2015-02, Vol.17 (2), p.215-221

2015

Volltextzugriff (PDF)

Source of inflammatory markers in patients with atrial fibrillation

Europace (London, England), 2008-07, Vol.10 (7), p.848-853

2008

Volltextzugriff (PDF)

The Cost-Effectiveness of Catheter Ablation as First-Line Treatment

Value in health, 2013-11, Vol.16 (7), p.A529-A529

2013

Volltextzugriff (PDF)

Prophylactic cavotricuspid isthmus block during atrial fibrillation ablation in patients without atrial flutter: a randomised controlled trial

Heart (British Cardiac Society), 2009-06, Vol.95 (12), p.994-999

2009

Volltextzugriff (PDF)

Five year follow-up of symptoms and health-related quality of life in patients with atrial fibrillation treated with catheter ablation

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

P3831Still neuroendocrine effects 4 months after radiofrequency ablation of atrial fibrillation

European heart journal, 2018-08, Vol.39 (suppl_1)

2018

Volltextzugriff (PDF)

Effect of ventricular tachycardia ablation on symptoms and health-related quality of life: data from a single-center registry

Europace (London, England), 2023-05, Vol.25 (Supplement_1)

2023

Volltextzugriff (PDF)

P4830Neurohormonal and echocardiographic predictors of recurrence of atrial fibrillation following radiofrequency ablation

European heart journal, 2018-08, Vol.39 (suppl_1)

2018

Volltextzugriff (PDF)

The clinical research office of the endourological society percutaneous nephrolithotomy global study: staghorn versus nonstaghorn stones

International Brazilian journal of urology, 2011-10, Vol.37 (5), p.661-661

2011

Volltextzugriff (PDF)

P353Predictors of recurrence after radiofrequency ablation of atrial fibrillation

Europace (London, England), 2017-06, Vol.19 (suppl_3), p.iii62-iii62

2017

Volltextzugriff (PDF)

Episodes of atrial fibrillation and atrial vulnerability after successful radiofrequency catheter ablation in patients with Wolff-Parkinson-White syndrome

Europace (London, England), 2002-04, Vol.4 (2), p.201-206

2002

Volltextzugriff (PDF)

Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial

International journal of cardiology, 2015-11, Vol.198, p.108-114

2015

Volltextzugriff (PDF)

PCV99 - The Cost-Effectiveness of Catheter Ablation as First-Line Treatment

Value in health, 2013-11, Vol.16 (7), p.A529-A529

2013

Volltextzugriff (PDF)

Cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation

European heart journal, 2013-08, Vol.34 (suppl 1), p.3534-3534

2013

Volltextzugriff (PDF)

The Impact of Supraventricular Tachycardias on Driving Ability in Patients Referred for Radiofrequency Catheter Ablation

Pacing and clinical electrophysiology, 2005-03, Vol.28 (3), p.191-195

2005

Volltextzugriff (PDF)

Sensing of Atrial Fibrillation by a Dual Chamber Pacemaker: How Should Atrial Sensing Be Programmed to Ensure Adequate Mode Shifting?

Pacing and clinical electrophysiology, 2000-07, Vol.23 (7), p.1089-1093

2000

Volltextzugriff (PDF)

Focal atrial tachycardia: increased electrogram fractionation in the vicinity of the earliest activation site

Europace (London, England), 2008-10, Vol.10 (10), p.1195-1204

2008

Volltextzugriff (PDF)

Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden (The MANTRA-PAF trial)

European heart journal, 2013-08, Vol.34 (suppl 1), p.P514-P514

2013

Volltextzugriff (PDF)

Gender-Related Differences in Patients With Atrioventricular Nodal Reentry Tachycardia

The American journal of cardiology, 2006-02, Vol.97 (3), p.384-388

2006

Volltextzugriff (PDF)

Catheter ablation--more effective than drugs

Läkartidningen, 2015-09, Vol.112

2015

Volltextzugriff (PDF)

The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) Trial: clinical rationale, study design, and implementation

Europace (London, England), 2009-07, Vol.11 (7), p.917-923

2009

Volltextzugriff (PDF)

Catheter ablation versus antiarrhythmic medication as first line therapy in paroxysmal atrial fibrillation: on treatment analysis of the MANTRA-PAF data

European heart journal, 2013-08, Vol.34 (suppl 1), p.3535-3535

2013

Volltextzugriff (PDF)

Focal atrial tachycardia: increased electrogram fractionation in the vicinity of the earliest activation site

Europace (London, England), 2008-11, Vol.10 (11), p.1357-1357

2008

Volltextzugriff (PDF)

Effects of AZD0837, a Novel Direct Thrombin Inhibitor, on the Electrophysiological Properties of the Human Heart: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study

Clinical drug investigation, 2010-01, Vol.30 (7), p.461-471

2010

Volltextzugriff (PDF)

Tissue oxygen pressure in normal myocardium and across the border zone during coronary artery occlusion in the pig. Effects of different arterial oxygen pressures

Basic research in cardiology, 1990-09, Vol.85 (5), p.467-480

1990

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(70)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial

Source of inflammatory markers in patients with atrial fibrillation

The Cost-Effectiveness of Catheter Ablation as First-Line Treatment

Prophylactic cavotricuspid isthmus block during atrial fibrillation ablation in patients without atrial flutter: a randomised controlled trial

Five year follow-up of symptoms and health-related quality of life in patients with atrial fibrillation treated with catheter ablation

P3831Still neuroendocrine effects 4 months after radiofrequency ablation of atrial fibrillation

Effect of ventricular tachycardia ablation on symptoms and health-related quality of life: data from a single-center registry

P4830Neurohormonal and echocardiographic predictors of recurrence of atrial fibrillation following radiofrequency ablation

The clinical research office of the endourological society percutaneous nephrolithotomy global study: staghorn versus nonstaghorn stones

P353Predictors of recurrence after radiofrequency ablation of atrial fibrillation

Episodes of atrial fibrillation and atrial vulnerability after successful radiofrequency catheter ablation in patients with Wolff-Parkinson-White syndrome

Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial

PCV99 - The Cost-Effectiveness of Catheter Ablation as First-Line Treatment

Cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation

The Impact of Supraventricular Tachycardias on Driving Ability in Patients Referred for Radiofrequency Catheter Ablation

Sensing of Atrial Fibrillation by a Dual Chamber Pacemaker: How Should Atrial Sensing Be Programmed to Ensure Adequate Mode Shifting?

Focal atrial tachycardia: increased electrogram fractionation in the vicinity of the earliest activation site

Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden (The MANTRA-PAF trial)

Gender-Related Differences in Patients With Atrioventricular Nodal Reentry Tachycardia

Catheter ablation--more effective than drugs

The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) Trial: clinical rationale, study design, and implementation

Catheter ablation versus antiarrhythmic medication as first line therapy in paroxysmal atrial fibrillation: on treatment analysis of the MANTRA-PAF data

Focal atrial tachycardia: increased electrogram fractionation in the vicinity of the earliest activation site

Effects of AZD0837, a Novel Direct Thrombin Inhibitor, on the Electrophysiological Properties of the Human Heart: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study

Tissue oxygen pressure in normal myocardium and across the border zone during coronary artery occlusion in the pig. Effects of different arterial oxygen pressures

Suchergebnisse filtern